ND4 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS: MODEL UTILIZING FIVE YEAR BENEFIT DATA

✍ Scribed by JP Caloyeras; B Harrow; C Wang; K Beckmann; V Knappertz; C Pohl; JD Miller; MW Russell; R Sandbrink; K Gondek

• Book ID: 118610727
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 88 KB
• Volume: 12
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)73129-6